Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
189
-
Total shares
-
108M
-
Shares change
-
+15.2M
-
Total reported value, excl. options
-
$1.61B
-
Value change
-
+$248M
-
Put/Call ratio
-
1.07
-
Number of buys
-
112
-
Number of sells
-
-76
-
Price
-
$14.91
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q3 2023
206 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q3 2023.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 108M shares
.
Largest 10 shareholders include Avoro Capital Advisors LLC (10.3M shares), BlackRock Inc. (7.79M shares), RA CAPITAL MANAGEMENT, L.P. (6.94M shares), JANUS HENDERSON GROUP PLC (6.8M shares), VANGUARD GROUP INC (5.75M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.13M shares), PERCEPTIVE ADVISORS LLC (4.04M shares), Cormorant Asset Management, LP (3.85M shares), JENNISON ASSOCIATES LLC (3.56M shares), and FRANKLIN RESOURCES INC (3.31M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.